Cargando…
Fibrin glue as a local drug-delivery system for bacteriophage PA5
Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or pos...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376040/ https://www.ncbi.nlm.nih.gov/pubmed/30765740 http://dx.doi.org/10.1038/s41598-018-38318-4 |
_version_ | 1783395482175799296 |
---|---|
author | Rubalskii, Evgenii Ruemke, Stefan Salmoukas, Christina Aleshkin, Andrey Bochkareva, Svetlana Modin, Evgeny Mashaqi, Bakr Boyle, Erin C. Boethig, Dietmar Rubalsky, Maxim Zulkarneev, Eldar Kuehn, Christian Haverich, Axel |
author_facet | Rubalskii, Evgenii Ruemke, Stefan Salmoukas, Christina Aleshkin, Andrey Bochkareva, Svetlana Modin, Evgeny Mashaqi, Bakr Boyle, Erin C. Boethig, Dietmar Rubalsky, Maxim Zulkarneev, Eldar Kuehn, Christian Haverich, Axel |
author_sort | Rubalskii, Evgenii |
collection | PubMed |
description | Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or postoperatively for deep wounds. However, prolonged local application of antibiotics is often not possible or simply inadequate. Biofilm formation and antibiotic resistance are also major obstacles to antibacterial therapy. In this paper we test the biocompatibility of bacteriophages incorporated within fibrin glue, track the release of bacteriophages from fibrin scaffolds, and measure the antibacterial activity of released bacteriophages. Fibrin glue polymerized in the presence of the PA5 bacteriophage released high titers of bacteriophages during 11 days of incubation in liquid medium. Released PA5 bacteriophages were effective in killing Pseudomonas aeruginosa PA01. Overall, our results show that fibrin glue can be used for sustained delivery of bacteriophages and this strategy holds promise for many antibacterial applications. |
format | Online Article Text |
id | pubmed-6376040 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63760402019-02-19 Fibrin glue as a local drug-delivery system for bacteriophage PA5 Rubalskii, Evgenii Ruemke, Stefan Salmoukas, Christina Aleshkin, Andrey Bochkareva, Svetlana Modin, Evgeny Mashaqi, Bakr Boyle, Erin C. Boethig, Dietmar Rubalsky, Maxim Zulkarneev, Eldar Kuehn, Christian Haverich, Axel Sci Rep Article Fibrin glue has been used clinically for decades in a wide variety of surgical specialties and is now being investigated as a medium for local, prolonged drug delivery. Effective local delivery of antibacterial substances is important perioperatively in patients with implanted medical devices or postoperatively for deep wounds. However, prolonged local application of antibiotics is often not possible or simply inadequate. Biofilm formation and antibiotic resistance are also major obstacles to antibacterial therapy. In this paper we test the biocompatibility of bacteriophages incorporated within fibrin glue, track the release of bacteriophages from fibrin scaffolds, and measure the antibacterial activity of released bacteriophages. Fibrin glue polymerized in the presence of the PA5 bacteriophage released high titers of bacteriophages during 11 days of incubation in liquid medium. Released PA5 bacteriophages were effective in killing Pseudomonas aeruginosa PA01. Overall, our results show that fibrin glue can be used for sustained delivery of bacteriophages and this strategy holds promise for many antibacterial applications. Nature Publishing Group UK 2019-02-14 /pmc/articles/PMC6376040/ /pubmed/30765740 http://dx.doi.org/10.1038/s41598-018-38318-4 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rubalskii, Evgenii Ruemke, Stefan Salmoukas, Christina Aleshkin, Andrey Bochkareva, Svetlana Modin, Evgeny Mashaqi, Bakr Boyle, Erin C. Boethig, Dietmar Rubalsky, Maxim Zulkarneev, Eldar Kuehn, Christian Haverich, Axel Fibrin glue as a local drug-delivery system for bacteriophage PA5 |
title | Fibrin glue as a local drug-delivery system for bacteriophage PA5 |
title_full | Fibrin glue as a local drug-delivery system for bacteriophage PA5 |
title_fullStr | Fibrin glue as a local drug-delivery system for bacteriophage PA5 |
title_full_unstemmed | Fibrin glue as a local drug-delivery system for bacteriophage PA5 |
title_short | Fibrin glue as a local drug-delivery system for bacteriophage PA5 |
title_sort | fibrin glue as a local drug-delivery system for bacteriophage pa5 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376040/ https://www.ncbi.nlm.nih.gov/pubmed/30765740 http://dx.doi.org/10.1038/s41598-018-38318-4 |
work_keys_str_mv | AT rubalskiievgenii fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT ruemkestefan fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT salmoukaschristina fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT aleshkinandrey fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT bochkarevasvetlana fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT modinevgeny fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT mashaqibakr fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT boyleerinc fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT boethigdietmar fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT rubalskymaxim fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT zulkarneeveldar fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT kuehnchristian fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 AT haverichaxel fibringlueasalocaldrugdeliverysystemforbacteriophagepa5 |